A selective LC-MS/MS method for simultaneous quantification of Artemether, Lumefantrine and their principle metabolites in human plasma

ABC Research Alert

View Publication Info
 
 
Field Value
 
Title A selective LC-MS/MS method for simultaneous quantification of Artemether, Lumefantrine and their principle metabolites in human plasma
 
Creator Ongas, Martin O.; Center for Research in Therapeutic Sciences, Strathmore University
Juma, Elizabeth; Centre for Clinical Research, Kenya Medical Research Institute
Kirimi, Caroline G; Center for Research in Therapeutic Sciences, Strathmore University
Oloo, Florence; Center for Research in Therapeutic Sciences, Strathmore University
Kokwaro, Gilbert; Center for Research in Therapeutic Sciences & Institute of Healthcare Management, Strathmore University
Aman, Rashid; Center for Research in Therapeutic Sciences, Strathmore University & African Centre for Clinical Trials (ACCT)
Ogutu, Bernhards R.; Center for Research in Therapeutic Sciences, Strathmore University & Centre for Clinical Research, Kenya Medical Research Institute
 
Subject Artemether; Lumefantrine; Metabolites; LC-MS/MS; Pharmacokinetics; Human plasma
 
Description We have developed and validated a sensitive, selective and reproducible reversed-phase high-performance liquid chromatography method coupled with electrospray ionization mass spectrometry (HPLC–ESI-MS/MS) for the simultaneous quantitation of artemether (ART), dihydroartemisinin (DHA), lumefantrine (LUM) and desbutyl-lumefantrine (DBL) in human plasma. Mefloquine was used as an internal standard (IS). The analytes were extracted by protein precipitation procedure and separated on a reversed-phase Zorbax SB-Ciano column with a mobile phase composed of acetonitrile and 20mM aqueous ammonium formate containing 0.5% (v/v) formic acid. Multiple reaction monitoring was performed in the positive ion mode using the transitions m/z 316.3→m/z 163.1 (ART), m/z 302.3→m/z 163.1 (DHA), m/z 530.3→m/z 512.2. (LUM), m/z 472.2→m/z 454.1 (DBL) and m/z 379.1→m/z 361.1(MQ) to quantify the drugs. Calibration curves in spiked plasma were linear (r2 ≥ 0.9992) over the range of 5–1500 ng/mL for ART/ DHA and 5–5,000 ng/mL for LUM/DBL. The lower limit of quantitation (LLOQ) was 10 ng/mL ART/ DHA and 5 ng/mL for LUM/ DBL. The mean R.S.D. values for the intra-run precision were 2.2% , 3.8%, 1.9%  and 4.7% and for the inter-run precision were 3.2%, 3.6% , 4.4%  and 3.5% for ART, DHA, LUM  and DBL, respectively. The mean percentage recovery values were 93.2%, 98.5%, 97.1% and 99.4% for ART, DHA, LUM and DBL, respectively. No matrix effect was detected for all the analytes and the IS. The validated method was successfully applied to determine the plasma concentrations of ART, DHA, LUM and DBL in pregnant and non-pregnant women volunteers in a multiple-dose pharmacokinetics study over the course of 336 hours.
 
Publisher Asian Business Consortium
 
Contributor
 
Date 2018-11-23
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format application/pdf
 
Identifier https://journals.abc.us.org/index.php/abcra/article/view/1137
10.18034/abcra.v6i3.1137
 
Source ABC Research Alert; Vol 6, No 3 (2018): September-December 2018 Issue; Kenya
10.18034/abcra.v6i3
 
Language eng
 
Relation https://journals.abc.us.org/index.php/abcra/article/view/1137/1023
 
Rights Copyright (c) 2018 Martin O. Ongas, Elizabeth Juma, Caroline G Kirimi, Florence Oloo, Gilbert Kokwaro, Rashid Aman, Bernhards R. Ogutu
http://creativecommons.org/licenses/by-nc/4.0
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2018 Simon Fraser University Library